Clinical Trial

AI-Assisted Non-Contrast CT for Multi-Cancer Screening

Recruiting
View on ClinicalTrials.gov →
Summary
Cancer poses a major public health challenge in China. Early detection can improve treatment outcomes and survival rates. In this study, we will conduct a large-scale, prospective, multi-center cohort study to evaluate the utility of AI-assisted non-contrast CT for multi-cancer screening. The study aims to enroll 1 million asymptomatic participants undergoing routine health examinations, using an AI imaging model based on non-contrast CT to detect seven cancers such as lung, liver, gastric, colorectal, esophageal, pancreatic, and breast cancers. Positive cases will be required to be referred to Shanghai Changhai Hospital for further imaging and care based on National Comprehensive Cancer Network (NCCN) and American College of Radiology (ACR) guidelines. The goal is to assess the AI model's diagnostic performance for seven cancer types, especially for early-stage, resectable tumors.
Trial Details
NCT Number NCT06632886
Lead Sponsor Guo ShiWei
Conditions Lung Cancers, Liver Cancer, Gastric Cancers, Colorectal, Cancer, Esophageal Cancer, Pancreatic Cancer, Breast Cancer
Enrollment 1,000,000 participants
Start Date 2024-10-07
Primary Completion 2026-10-07 (estimated)
Study Completion 2027-10-07 (estimated)
Updated on ClinicalTrials.gov 2024-10-09